Therefore, further studies are urgently needed to gain a better understanding on how activation of the IKK-NFκB pathway regulates tumor cell sensitivity to IR and chemotherapy before a molecular targeted therapy against the IKK-NFκB pathway can be effectively employed for cancer treatment. Here, NFKB1 is linked to neoplasm.